AKT1 and cancer: KEGG signaling pathway analysis showed that AS-IV was associated with EGFR tyrosine kinase inhibitor resistance, proteoglycans and pathways in cancer, chemical carcinogenesis-receptor activation, endocrine resistance, and PI3K/AKT signaling pathway was also highly correlated (Fig. 3H).